Clinical Assessment, Neuroimaging and Immunomarkers in Chagas Disease Study (CLINICS) "CLINICS"
Recruiting
Phase 4 Results N/ASummary of Purpose
The main purpose of the study is to determine noninvasive markers of brain involvement in Chagas disease. In a subgroup of patients with high intensity transient signals (HITS) on transcranial Doppler monitorization, the investigators aim to determine the efficacy and safety of aspirin in preventing microembolization in patients with no previous history of stroke. Specific aims are listed bellow: (1) to...
Read More →Trial Milestones
The following dates are available for this trial. Trial information last updated on 25 July 2012.
| 1 Jul 2012 | 24 Jul 2012 | 1 Sep 2016 | 1 Sep 2016 | 1 Jul 2012 | Unavailable |
| Start Date | First Received | 1st Completion | Completion | Verification | Results |
|---|
Trial Basics
Interventions
Conditions
Sponsors
Trial Design
- Allocation: Randomized
- Masking: Single Blind (Outcomes Assessor)
- Purpose: Treatment
- Endpoint: Safety/Efficacy Study
- Intervention: Parallel Assignment
Contacts
- Jamary Oliveira-Filho, MD, PhD
View Trial Locations
Recruitment
- Enrollment: 500
- Gender: Both
- Minimum Age: 18 Years
- Accepts Healthy Volunteers: No
- 1 location, 1 country
Principal Investigator
- Jamary Oliveira-Filho, MD, PhD
